Lottery scores in 2006

Mifal Hapayis recorded its best year in history in 2006, earning NIS 3.6 billion, the company said Monday.

By LEAH GRANOF
January 9, 2007 08:06

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Mifal Hapayis recorded its best year in history in 2006, earning NIS 3.6 billion, the company said Monday. The earnings reflect 9% growth from 2005 and the largest intake the lottery has posted since its founding 55 years ago. The lottery will keep NIS 795 million in profits and return NIS 3b. to the community. Out of the NIS 3b., Mifal Hapayis will invest NIS 800m. in community projects, primarily educational scholarships and the construction of educational infrastructure. The remainder will be given out in prize money. Last year, Mifal Hapayis created 61 new millionaires through the distribution of prize money.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS